Software Design Control Engineer
Echo Neurotechnologies
Software Design Control Engineer
Echo Neurotechnologies
Implantable brain-computer interface enabling communication
Echo Neurotechnologies is an exciting new startup in the Brain-Computer Interface (BCI) space, driving innovation through advanced hardware engineering and AI solutions. Our mission is to deliver cutting-edge technologies that restore autonomy to people living with disabilities and improve their quality of life.
Join a small, dedicated team of knowledgeable and motivated professionals. Our early-stage environment offers the opportunity to take ownership of broad decisions with significant and long-lasting impact. We emphasize continuous learning and growth, fostering cross-functional collaboration where your contributions are vital to our success.
We are seeking a Software Design Control Engineer to drive end-to-end documentation and process rigor across our Class III medical device software products, supporting both clinical trials and commercialization. This role sits at the intersection of software engineering, quality systems, and regulatory compliance. You will bring medical device best practices across quality and engineering to ensure our software is safe, effective, compliant, and ready for market.
An opportunity to work on exciting, cutting-edge projects to transform patients’ lives in a highly collaborative work environment.
Competitive compensation, including stock options.
Comprehensive benefits package.
401(k) program with matching contributions.
Echo Neurotechnologies is an Equal Opportunity Employer (EOE). We celebrate diversity and are committed to creating an inclusive environment for all employees.
All applications will be treated confidentially. Applicants may be asked to sign an NDA after the initial stages of the interview process.
Salary 170000 - 220000 USD
Implantable brain-computer interface enabling communication
Echo Neurotechnologies creates brain-computer interfaces (BCIs) aimed at helping people with severe neurological disabilities regain abilities such as conversational communication. Its main product is an implantable BCI system that surgically places electrodes on the brain to record neural signals, which are then decoded by software (potentially using AI) to control external devices or generate speech through a digital avatar. This makes it possible for users to interact with computers or robotic limbs by thinking. The company differentiates itself through leadership from Dr. Edward Chang and a focus on clinically translating BCIs for restoration of communication and movement, backed by venture funding from Andreessen Horowitz and a plan to move toward commercialization in a field with players like Neuralink and Synchron. The goal is to bring therapeutic neural implants to patients, enabling restored communication and mobility for those with severe paralysis.
Explore more opportunities at Echo Neurotechnologies